Kimberly Jerdan, MD
Dermatology · Oklahoma City, OKNPI 1821431891
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $52,290 of the $59,281 with a category attached, or 88.2%. Galderma Laboratories, L.p. accounts for 94.5% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2022 at $22,858 and has fallen 97.4% since, to $587 in 2025. Among dermatology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $264.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$56K
- Arcutis Biotherapeutics, Inc.$632
- UCB, Inc.$624
- Lilly USA, LLC$387
- Regeneron Healthcare Solutions, Inc.$357
- AbbVie$351
- plus $884 from 19 others
What the payments were for
- Consulting fees$1,8753%
- Speaking & faculty fees$52,29088%
- Travel & lodging$1,1772%
- Food & beverage$3,8927%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 63 | $56,047 |
| Arcutis Biotherapeutics, Inc. | 42 | $632 |
| UCB, Inc. | 32 | $624 |
| Lilly USA, LLC | 16 | $387 |
| Regeneron Healthcare Solutions, Inc. | 13 | $357 |
| AbbVie(2 entities) | 14 | $351 |
| Novartis | 7 | $149 |
| Pfizer | 7 | $133 |
| Sanofi | 5 | $112 |
| Revance Therapeutics, Inc. | 4 | $103 |
| Kyowa Kirin, Inc. | 3 | $69 |
| Sun Pharmaceutical Industries Inc. | 3 | $49 |
| Johnson & Johnson | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Amgen | 1 | $33 |
| DUSA Pharmaceuticals, Inc. | 1 | $21 |
| Strata Skin Sciences, Inc. | 1 | $20 |
| Prugen, Inc. Pharmaceuticals | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| VYNE Pharmaceuticals Inc. | 1 | $11 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,281 in reported general payments places this provider in the 95th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 11 | $382 |
| Ketoconazole | 23 | $235 |
| Triamcinolone Acetonide | 32 | $235 |
| ValacyclovirValacyclovir Hcl | 12 | $196 |
| Doxycycline Hyclate | 13 | $183 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
- Courtney CookOklahoma City$10K
- Clifford HendersonOklahoma City$9K
- Roy RindlerOklahoma City$9K
- Emily ArchbaldOklahoma City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.